首页> 美国卫生研究院文献>other >Crystalloid fluid administration was associated with outcomes in pediatric patients with severe sepsis or septic shock
【2h】

Crystalloid fluid administration was associated with outcomes in pediatric patients with severe sepsis or septic shock

机译:小儿败血症或脓毒性休克的儿科患者服用晶体液与预后相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Intravenous fluid prescription plays an important role in sepsis management, which may be associated with patient prognosis. The objective of the present study was to determine if the administration of crystalloid fluids is associated with clinical outcome for patients with severe sepsis and septic shock.The medical records of 79 patients with severe sepsis or septic shock at an academic tertiary care hospital between 2011 and 2016 were reviewed retrospectively. The patients were dichotomized based on the median 3-day amount of corrected crystalloid fluids as low (<193 mL/kg) versus high (>193 mL/kg). The primary outcome measure was mortality. Secondary outcome measures included length of stay in the pediatric intensive care unit (PICU), usage of mechanical ventilation, etc.The most common bacterial pathogens were Escherichia coli and Klebsiella spp. with a strikingly high number of multidrug-resistant infections (10.1%). The most common site of infection was of abdominal origin. Patients who received larger amounts of crystalloids were more likely to have lower weight and underlying comorbidities (high PRISM score). Although fluid intake was different in the 2 groups, output volumes were almost the same; therefore, a positive fluid balance was present in the high crystalloid patients. The incidence of mortality increased as the accumulated 3-day amount of crystalloid fluids administered increased. The total length of stay in the PICU was longer for patients who received high volume crystalloid fluid (15.8 ± 7.8 days) than for patients who received the lower volume (9.7 ± 5.3 days, P = .026).A higher amount of 3-day crystalloid administration was unfavorable for postoperative outcomes in children with sepsis and septic shock; these patients experienced higher PICU mortality, longer PICU stays, and more ventilator days. More study on the benefits and harms of fluid in children are needed to improve patient safety and the quality of care that would facilitate better outcomes.
机译:静脉输液处方在脓毒症管理中起重要作用,这可能与患者的预后有关。本研究的目的是确定2011年至2011年间,在一家三级学术医院中,对于患有严重败血症和败血性休克的患者,是否服用晶体液与临床结局是否相关.79例患有严重败血症或败血性休克的患者的医疗记录回顾性审查2016年。根据校正后的晶体液的中位数3天(低(<193(mL / kg)对高(> 193 mL / kg)对患者进行二分。主要结果指标是死亡率。次要结果指标包括在小儿重症监护室(PICU)的住院时间,使用机械通气等,最常见的细菌病原体是大肠杆菌和克雷伯菌。且耐多药感染的人数惊人地多(10.1%)。最常见的感染部位是腹部。接受大量晶体的患者体重和潜在合并症的可能性更高(PRISM评分较高)。尽管两组的体液摄入量不同,但输出量几乎相同。因此,高晶体患者中存在正的液体平衡。死亡率的发生随着所用晶体液3天累积给药量的增加而增加。接受大剂量晶体液的患者(15.8±7.8天)比接受小剂量晶体液的患者(9.7±5.3天,P = .026)更长,其在PICU的总住院时间更长。3-脓毒症和败血性休克患儿术后一天使用晶体注射剂不利于术后结果。这些患者的PICU死亡率更高,PICU停留时间更长,呼吸机天数更多。需要对儿童输液的利弊进行更多研究,以提高患者安全性和护理质量,从而促进更好的治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号